Thalidomide-O-C7-acid
Modify Date: 2024-01-09 16:58:29
Thalidomide-O-C7-acid structure
|
Common Name | Thalidomide-O-C7-acid | ||
|---|---|---|---|---|
| CAS Number | 2169266-70-8 | Molecular Weight | 416.42 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H24N2O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thalidomide-O-C7-acidThalidomide-O-C7-acid is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
| Name | Thalidomide-O-C7-acid |
|---|
| Description | Thalidomide-O-C7-acid is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| References |
| Molecular Formula | C21H24N2O7 |
|---|---|
| Molecular Weight | 416.42 |
| Hazard Codes | Xi |
|---|